| __timestamp | Novavax, Inc. | TG Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 79435000 | 31354781 |
| Thursday, January 1, 2015 | 162644000 | 43445817 |
| Friday, January 1, 2016 | 237939000 | 66489820 |
| Sunday, January 1, 2017 | 168435000 | 96886134 |
| Monday, January 1, 2018 | 173797000 | 153793000 |
| Tuesday, January 1, 2019 | 113842000 | 148369000 |
| Wednesday, January 1, 2020 | 747027000 | 151934000 |
| Friday, January 1, 2021 | 2534508000 | 198532000 |
| Saturday, January 1, 2022 | 1235278000 | 112128000 |
| Sunday, January 1, 2023 | 737502000 | 76192000 |
Igniting the spark of knowledge
In the ever-evolving world of biotechnology, research and development (R&D) spending is a key indicator of a company's commitment to innovation. Over the past decade, Novavax, Inc. and TG Therapeutics, Inc. have demonstrated contrasting approaches to R&D investment. From 2014 to 2023, Novavax's R&D expenses surged by over 900%, peaking in 2021 with a staggering 2.5 billion dollars, largely driven by their COVID-19 vaccine efforts. In contrast, TG Therapeutics maintained a steady growth, with a 530% increase, reaching its highest R&D expenditure in 2021 at nearly 200 million dollars. This comparison highlights Novavax's aggressive investment strategy, while TG Therapeutics adopts a more measured approach. As the biotech landscape continues to shift, these spending patterns offer insights into each company's strategic priorities and potential future breakthroughs.
Comparing Innovation Spending: Eli Lilly and Company and TG Therapeutics, Inc.
R&D Spending Showdown: Zoetis Inc. vs Novavax, Inc.
Research and Development: Comparing Key Metrics for Takeda Pharmaceutical Company Limited and TG Therapeutics, Inc.
Biogen Inc. or Novavax, Inc.: Who Invests More in Innovation?
R&D Spending Showdown: Genmab A/S vs TG Therapeutics, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Ascendis Pharma A/S and Novavax, Inc.
Comparing Innovation Spending: Ionis Pharmaceuticals, Inc. and Novavax, Inc.
R&D Insights: How Opthea Limited and Novavax, Inc. Allocate Funds
Research and Development: Comparing Key Metrics for Axsome Therapeutics, Inc. and TG Therapeutics, Inc.
TG Therapeutics, Inc. vs Catalyst Pharmaceuticals, Inc.: Strategic Focus on R&D Spending
Research and Development: Comparing Key Metrics for Viking Therapeutics, Inc. and Novavax, Inc.
Analyzing R&D Budgets: Veracyte, Inc. vs Novavax, Inc.